Advertisement


Emily S. Tonorezos, MD, on Childhood Cancer Survivors and Late-Occurring Effects

2017 Cancer Survivorship Symposium

Advertisement

Emily S. Tonorezos, MD, of Memorial Sloan Kettering Cancer Center, discusses childhood cancer survivors and the protection from late-occurring anthracycline-related cardiotoxicity conferred by a RARG coding variant.



Related Videos

Genomics/Genetics

Angela R. Bradbury, MD, on Genetic Information and Clinical Care

Angela R. Bradbury, MD, of the University of Pennsylvania, discusses genetic testing, tumor profiling, and the identification of those at increased risk for second cancers.

Survivorship

Allison Harvey, MPH, CHES, on Teaching Providers About Survivorship

Allison Harvey, MPH, CHES, of George Washington University, evaluates preliminary outcomes among primary care and oncology providers who took part in the Cancer Survivorship E-Learning Series (Abstract 78).

Thyroid Cancer
Survivorship

Dong Wook Shin, MD, DrPH, MBA, on Thyroid Cancer: Risk of Side Effects

Dong Wook Shin, MD, DrPH, MBA, of Seoul National University Cancer Hospital, discusses the risk of coronary heart disease and ischemic stroke in patients with thyroid cancer taking levothyroxine (Abstract 105).

Survivorship

K. Holly Mead, PhD, on Identifying Models of Cancer Survivorship Care

K. Holly Mead, PhD, of George Washington University, discusses specialized survivorship-specific programs, which are gaining prominence, with over 40% of cancer centers in her study providing this type of care (Abstract 1).

Breast Cancer
Survivorship

Shawna V. Hudson, PhD, on Breast Cancer: A Quality-of-Life Program

Shawna V. Hudson, PhD, of Rutgers University, discusses a survivorship program designed to improve the quality of life for Hispanic and Latino breast cancer survivors (Abstract 183).

Advertisement

Advertisement




Advertisement